Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Personalised medicine for multiple sclerosis care.
Patient wins right to care at home.
Time interval after ischaemic preconditioning affects neuroprotection and gliosis in the gerbil hippocampal CA1 region induced by transient cerebral ischaemia.
Volumetric and Shape Analysis of the Thalamus and Striatum in Amnestic Mild Cognitive Impairment.
Neurofilament in CSF-A biomarker of disease activity and long-term prognosis in multiple sclerosis.
CellCept (Product Insert)
Coexistence of rheumatoid arthritis, ankylosing spondylitis and dermatomyositis in a patient with diabetes mellitus and the associated linked HLA antigens.
Genetic modifications associated with ketogenic diet treatment in the BTBR(T+Tf/J) mouse model of autism spectrum disorder.
Lumican negatively controls the pathogenicity of murine encephalitic TH17 cells.
Using EP50 to forecast treatment adherence in individuals with multiple sclerosis.
Delayed administration of recombinant human erythropoietin reduces apoptosis and inflammation and promotes myelin repair and functional recovery following spinal cord compressive injury in rats.
The High Prevalence of the Varicella Zoster Virus in Patients With Relapsing-Remitting Multiple Sclerosis: A Case-Control Study in the North of Iran.
Corrigendum to "Expression of DNA methylation genes in secondary progressive multiple sclerosis" [J. Neuroimmunol. 290 (2016 Jan. 15) 66-9].
Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues.
NT-3 promotes proprioceptive axon regeneration when combined with activation of the mTor intrinsic growth pathway but not with reduction of myelin extrinsic inhibitors.
Headache in stroke according to National Acute Stroke Israeli Survey.
T1 relaxometry of crossing fibres in the human brain.
Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study.
Insights into the Pathogenesis and Treatment of Krabbe Disease.
Brain health: time matters in multiple sclerosis.
Baseline EDSS proportions in MS clinical trials affect the overall outcome and power: A cautionary note.
NG2-glia, More Than Progenitor Cells.
Comparison of Percutaneous Retrograsserian Balloon Compression and Gamma Knife Radiosurgery for the Treatment of Trigeminal Neuralgia in Multiple Sclerosis: A Clinical Research Study Article.
Prothrombin and factor X are elevated in multiple sclerosis patients.
Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies.
Pages
« first
‹ previous
…
755
756
757
758
759
760
761
762
763
…
next ›
last »